← Back to Search

Transition Coaching for Juvenile Arthritis (TRACER Trial)

N/A
Recruiting
Led By Michelle Batthish, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 year study period
Awards & highlights
No Placebo-Only Group

Summary

This trial will help find out if transition coaching sessions can help young people with rheumatology conditions move from paediatric to adult care.

Who is the study for?
This trial is for young people with pediatric-onset rheumatic diseases like arthritis and lupus, who are transitioning to adult care. Participants need a phone or device for video calls, must be available for the next 8 months, and able to communicate in English. Those with cognitive impairments that prevent participation in educational sessions cannot join.
What is being tested?
The TRACER study is testing transition coaching sessions designed to help patients move from pediatric to adult rheumatology care smoothly. The feasibility of these coaching interventions through video conferencing will be evaluated.
What are the potential side effects?
Since this trial involves non-medical intervention (coaching), there are no direct physical side effects associated with medications or procedures. However, participants may experience stress or anxiety related to the transition process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 year study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 year study period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Consent rate
Enrolment from non-primary site
Missing data
+2 more
Secondary study objectives
Active joint count
Global function/quality of life
Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Transition coaching - experimentalExperimental Treatment1 Intervention
Participants will receive 8 transition coaching sessions (1/month) in addition to standard care
Group II: Standard care - controlActive Control1 Intervention
Standard of care, appointments with adult rheumatology

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
916 Previous Clinical Trials
2,615,095 Total Patients Enrolled
Western UniversityOTHER
29 Previous Clinical Trials
128,598 Total Patients Enrolled
Michelle Batthish, MDPrincipal InvestigatorMcMaster University

Media Library

Transition coaching Clinical Trial Eligibility Overview. Trial Name: NCT05545839 — N/A
Juvenile Dermatomyositis Research Study Groups: Standard care - control, Transition coaching - experimental
Juvenile Dermatomyositis Clinical Trial 2023: Transition coaching Highlights & Side Effects. Trial Name: NCT05545839 — N/A
Transition coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05545839 — N/A
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top